About: Should the Management of Embolic Stroke in the Elderly Be Changed if They Also Have COVID-19?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Should the Management of Embolic Stroke in the Elderly Be Changed if They Also Have COVID-19? Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Should the Management of Embolic Stroke in the Elderly Be Changed if They Also Have COVID-19?
Creator	Fagundes, Vítor Mesquita, Mari Nogueira, Luís Rocha, João Seabra, Carolina Silva, Bárbara
source	Medline; PMC; WHO
abstract	INTRODUCTION: A strong association between stroke and atrial fibrillation (AF) has been demonstrated. Anticoagulation for the prevention of stroke in high-risk patients has the benefit of improving the life expectancy, quality of life, autonomy and social functioning of the patient. The COVID-19 pandemic poses challenges for stroke patients because of the association between SARS-CoV-2 infection and thromboembolic risk. CASE DESCRIPTION: We describe the case of an 84-year-old female patient admitted due to an embolic stroke and non-anticoagulated AF. Her admission symptoms were sensory-motor aphasia and severe right limb paresis with an NIHSS score of 24. The diagnosis of embolic stroke (namely, total anterior circulation infarct; TACI) was made. Her stroke was extensive so she was not started on anticoagulation. During hospitalization, new embolic events occurred and a concomitant diagnosis of COVID-19 was made with progressive respiratory dysfunction followed by multiorgan failure. The patient died despite appropriate treatment. DISCUSSION: The prognosis of elderly patients with cardioembolic stroke depends on anticoagulation administration. The NIHSS score on admission of our patient meant anticoagulation therapy was not appropriate. The diagnosis of COVID-19 contributed to the patient’s death. LEARNING POINTS: Anticoagulation should be considered in stroke patients with total infarction and atrial fibrillation. There is an association between COVID-19 and thromboembolic stroke. Elderly patients with stroke and COVID-19 are at higher risk of death.
has issue date	2020-05-25(xsd:dateTime)
bibo:doi	10.12890/2020_001736
bibo:pmid	32523932
has license	cc-by-nc
sha1sum (hex)	94519c3ea1e21f1e590b1f84f6d0426395e00eb0
schema:url	https://doi.org/10.12890/2020_001736
resource representing a document's title	Should the Management of Embolic Stroke in the Elderly Be Changed if They Also Have COVID-19?
has PubMed Central identifier	PMC7279903
has PubMed identifier	32523932
schema:publication	Eur J Case Rep Intern Med
resource representing a document's body	covid:94519c3ea1e21f1e590b1f84f6d0426395e00eb0#body_text
is schema:about of	named entity 'stroke' named entity 'hospitalization' named entity 'poses' named entity 'diagnosis' named entity 'Internal Medicine' named entity 'Reports' named entity 'Internal Medicine' named entity 'describe' named entity 'diagnosis' named entity 'life expectancy' named entity 'infection' named entity 'symptoms' named entity 'TACI' named entity 'limb' named entity 'NIHSS' named entity 'Stroke' named entity 'Case' named entity 'EFIM' named entity 'Reports' named entity 'elderly patients' named entity 'NIHSS' named entity 'stroke' named entity 'stroke patients' named entity 'SARS-CoV-2' named entity 'infection' named entity 'cardioembolic' named entity 'COVID-19 pandemic' named entity 'NIHSS' named entity 'prognosis' named entity 'limb paresis' named entity 'anticoagulation' named entity 'quality of life' named entity 'anticoagulation therapy' named entity 'stroke' named entity 'Case Reports' named entity 'COVID-19' named entity 'European Journal' named entity 'NIHSS' named entity 'medical treatment' named entity 'respiratory distress' named entity 'infarction' named entity 'ultrasound' named entity 'hypertension' named entity 'chest CT' named entity 'mg/dl' named entity 'NIHSS' named entity 'mmHg' named entity 'life expectancy' named entity 'National Institutes of Health Stroke Scale' named entity 'anticoagulation' named entity 'external carotid artery' named entity 'hemiplegia' named entity 'triglycerides' named entity 'infarct' named entity 'homonymous hemianopsia' named entity 'stenosis' named entity 'middle cerebral artery' named entity 'mg/dl' named entity 'subcortical' named entity 'ARDS' named entity 'risk factors' named entity 'anticoagulation therapy' named entity 'HbA1C' named entity 'NIHSS' named entity 'European Heart Rhythm Association' named entity 'ischaemia' named entity 'heart rate' named entity 'thrombolysis' named entity 'embolic' named entity 'COVID' named entity 'sensory-motor' named entity 'anticoagulation' named entity 'COVID-19' named entity 'chest x-ray' named entity 'mg/dl' named entity 'cerebral infarction'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software